HEOR scientists in the pharma industry must balance methodologic rigor with commercial expectations and timelines.
As local payers come under more pressure to constrain costs, the value of Health Economics and Outcomes Research (HEOR) is increasing. The involvement of market access teams at every stage of ...
The recent shift in Health Economics and Outcomes Research functions across major pharmaceutical companies highlights a lack of understanding of its value. Health Economics and Outcomes Research (HEOR ...
Over the past year, several global biopharmaceutical firms have substantially reorganized their health economics and outcomes research (HEOR) groups. Specifically, the leaders of the groups have ...
Market Growth: The HEOR services market is expected to reach US$ 3.79 billion by 2031 from US$ 1.68 billion in 2024, at a CAGR of 12.3% during the forecast period. HEOR services encompass various ...